Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-25

FDA Approved: GLATIRAMER ACETATE — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical Industries' original ANDA for glatiramer acetate, a generic version of the multiple sclerosis treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLATIRAMER ACETATE (GLATIRAMER ACETATE)

Snippet

ORIG AP for GLATIRAMER ACETATE (GLATIRAMER ACETATE)